NCT05104736 2026-04-07
PT-112 in Subjects With Thymoma and Thymic Carcinoma
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
Clinical Trials
18 trialsNCT07132918 2026-03-11
HEARTS Trial for Thoracic Cancers
University of Wisconsin, Madison
Phase 2 Recruiting
NCT06885697 2026-02-17
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
National Institutes of Health Clinical Center (CC)
Phase 1 Recruiting
NCT03295227 2026-01-30
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT06248515 2026-01-27
A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors
Georgetown University
Phase 2 Recruiting
NCT06838910 2025-12-01
Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Recruiting
NCT06790706 2025-10-06
IMMUNORARE5
Hospices Civils de Lyon
Phase 2 Recruiting
NCT07181720 2025-10-02
CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors
Chongqing Precision Biotech Co., Ltd
Phase 1 Recruiting
NCT06186726 2025-06-13
Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors
Shanghai Proton and Heavy Ion Center
Phase 2 Recruiting
NCT06545409 2025-03-25
SPRATS
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase NA Recruiting
NCT06730308 2024-12-12
Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma
Sun Yat-sen University
Phase 2 Recruiting
NCT06692062 2024-11-18
Hypofractionated Radiotherapy for Thymic Epithelial Tumors
Xiangya Hospital of Central South University
Phase NA Recruiting
NCT06402708 2024-05-10
Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)
Fudan University
Phase 3 Recruiting
NCT06029621 2024-02-29
Robot-assisted vs VATS for Thymoma
Shanghai Pulmonary Hospital, Shanghai, China
Phase NA Recruiting
NCT02633553 2023-12-08
Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection
Fudan University
Phase NA Recruiting
NCT02633514 2023-12-05
Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma
Fudan University
Phase 3 Recruiting
NCT05832827 2023-10-23
Artemis
National Cancer Center, Japan
Phase 2 Recruiting
NCT04822077 2021-03-30
PROTHYM
Swedish Lung Cancer Study Group
Phase NA Recruiting